Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck
Christopher L. Hallemeier(Mayo Clinic in Arizona), Robert L. Foote(Mayo Clinic), M.A. Neben-Wittich(Mayo Clinic), Wonwoo Shon(Mayo Clinic), Yolanda I. Garces(Mayo Clinic), Joaquín J. García(Mayo Clinic), Kenneth R. Olivier(Mayo Clinic), Paul D. Brown(Mayo Clinic)
Cited by 10
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k